Ocumension Therapeutics posts HY adjusted net loss of RMB57.5M
Ocumension Therapeutics reported HY adjusted net loss of RMB57.5 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.